Clinical Trial Update: Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma [Phase 2]

View source ↗

Summary

Phase II multicenter study of talimogene laherparepvec in classic or endemic Kaposi sarcoma is ongoing; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Talimogene laherparepvec (talimogene laherparepvec)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Kaposi Sarcoma | Phase 2 | Status: UNKNOWN